Session » B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's
-
Abstract Number: 1075
CD40-Pathway Activation in Ectopic Lymphoid Structure (ELS)-Resident B Cells Contributes to Disease Pathology in Primary SjöGren’s Syndrome
-
Abstract Number: 1076
BAFF Receptor Antagonists Suppress Differentiation of B Cells in Vitro and Are Drug Candidates for Primary SjöGren’s Syndrome
-
Abstract Number: 1078
Elevated Proportion of CD38highIgD+ b Cells in Peripheral Blood Is Related to Disease Activity in Patients with Primary SjöGren’s Syndrome
-
Abstract Number: 1079
Discovery of Novel Autoantigens in Sjogren’s Syndrome with Potential for Subgrouping of Disease
-
Abstract Number: 1080
B-Cell Clonal Expansions in Parotid Glands of Sjogren’s Patients Are Associated with Increased Numbers of N-Glycosylation Motifs in the Immunoglobulin Heavy Chain Genes
-
Abstract Number: 1082
Type I/II Interferon Commits to Abnormal Expression of Chemokine Receptor on B Cells in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1083
Discovery and Subsequent Diagnostic Verification of Autoantibodies Against the Major Vault Protein (MVP) in Systemic Lupus Erythematosus
-
Abstract Number: 1084
Antibodies to Native Vimentin in Lupus: Characterization, Isotypes, Origins, and Associations with Other Autoimmune Pathways
-
Abstract Number: 1085
The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients
-
Abstract Number: 1086
Analysis of the Naive B Cell Repertoire in Belimumab Treated SLE Patients
-
Abstract Number: 1087
Nonmemory B Cell Signature Alterations in Belimumab Patients
-
Abstract Number: 1088
Expansion of Transitional B Cells in SLE Patients Correlates with Increased Toll-like Receptor 7 Expression
-
Abstract Number: 1090
CpG-Stimulated B Cells Require Glutaminolysis for Glycolysis, Mitochondrial Respiration, and Cytokine Production
-
Abstract Number: 1091
Synergistic Immunoregulatory Effects of IL-10 and TGF-β on Humoral Immunity